In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Cg Oncology Inc.’s stock clocked out at $31.33, down -5.26% from its previous closing price of $33.07. In other words, the price has decreased by -$5.26 from its previous closing price. On the day, 0.66 million shares were traded. CGON stock price reached its highest trading level at $33.32 during the session, while it also had its lowest trading level at $30.975.
Ratios:
To gain a deeper understanding of CGON’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 57.95 and its Current Ratio is at 57.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $65.
On February 20, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $55.
On February 20, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $42.Goldman initiated its Neutral rating on February 20, 2024, with a $42 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 29 ’24 when Decheng Capital Global Life Sc bought 400,000 shares for $19.00 per share. The transaction valued at 7,600,000 led to the insider holds 400,000 shares of the business.
Song Hong Fang bought 263,157 shares of CGON for $4,999,983 on Jan 29 ’24. The Director now owns 613,928 shares after completing the transaction at $19.00 per share. On Jan 29 ’24, another insider, Roche Corleen M., who serves as the CFO & Secretary of the company, bought 2,000 shares for $19.00 each. As a result, the insider paid 38,000 and bolstered with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2087837440 and an Enterprise Value of 1521731840. Its current Enterprise Value per Revenue stands at 2823.25 whereas that against EBITDA is -22.319.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -5.50%, while the 200-Day Moving Average is calculated to be -14.74%.
Shares Statistics:
It appears that CGON traded 693.03K shares on average per day over the past three months and 716310 shares per day over the past ten days. A total of 66.64M shares are outstanding, with a floating share count of 40.71M. Insiders hold about 38.90% of the company’s shares, while institutions hold 43.83% stake in the company. Shares short for CGON as of 1721001600 were 5853407 with a Short Ratio of 8.45, compared to 1718323200 on 4299846. Therefore, it implies a Short% of Shares Outstanding of 5853407 and a Short% of Float of 8.870000000000001.
